LUPIN
Back to Income Statement
|
LUPIN Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹22,708 Cr | ₹20,011 Cr | ₹16,642 Cr | ₹16,405 Cr | ₹15,163 Cr |
What is the latest Revenue of LUPIN ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹22,708 Cr |
| Mar2025 | ₹20,011 Cr |
| Mar2024 | ₹16,642 Cr |
| Mar2023 | ₹16,405 Cr |
| Mar2022 | ₹15,163 Cr |
How is Revenue of LUPIN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹22,708 Cr | 13.48 | |
| Mar2025 | ₹20,011 Cr | 20.25 | |
| Mar2024 | ₹16,642 Cr | 1.44 | |
| Mar2023 | ₹16,405 Cr | 8.19 | |
| Mar2022 | ₹15,163 Cr | - | |
Compare Revenue of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹108,331.3 Cr | -4.4% | 0.1% | 22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -4.4% |
0.1% |
22.5% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses